8
36
A. ZAKI ET AL.
temperature. The combined extracts were collected and
evaporated to dryness under reduced pressure at 40°C.
The residue, 90g, was suspended in distilled water and
extracted successively with methylene chloride, EtOAc
and n-butanol. The different extracts were evaporated
under reduced pressure to obtain methylene chloride
fraction (fraction A, 25 g) and EtOAc fraction (fraction B,
cells. So, for the other well plate, 50 μL of MTT reagent
in PBS (250 μg/mL) was added to each well. The plates
were incubated in a humidified atmosphere of 5% of
CO at 37°C for 4h. After the medium was removed,
2
1.0-mL isopropyl alcohol (containing 0.04N HCl) was
added, and the absorbance was measured at 570nm af-
ter overnight keeping in dark.
2
0 g) and n-butanol fraction (fraction C, 15 g); the n-butanol
fraction was selected for further study.
Hyaluronic acid (HA) ELISA assay on (NHDF-Ad).
The isolated compounds were tested for the effect of
the production of HA by the use of HA ELISA assay
using Biotech Trading Partners (Encinitas, California)
according to the manufacturer’s instruction.
Isolation of compounds. Three grams of fraction C was
dissolved totally in the smallest volume of methanol
(
1–2 mL) and then mixed well with about 3-g RP18 silica
gel and left at room temperature to dry and applied onto
the top of a silica gel packed (RP ) glass column (120g,
This kit is an enzyme-linked binding protein assay
that uses a capture molecule known as HA binding pro-
tein (HABP). After growing of the fibroblast cells, they
are incubated in HABP-coated micro well plate. Prop-
erly samples and HA reference solution are added to
this plate, allowing HA present to react with the
immobilized binding protein. After removal of unbound
molecules by washing, HABP conjugated with horse-
radish peroxidase (HRP) solution is added to the
microwells to form complexes with bound HA. Follow-
ing another washing step, a chromogenic substrate of
tetramethylbenzidine and hydrogen peroxide is added
to develop a colored reaction. The intensity of the color
is measured in optical density units with a spectropho-
tometer at 450nm. The higher the intensity of the color,
the higher ability of the sample to produce HA.
1
8
3
3× 3.7cm) pre-packed in water. Isocratic elution was
carried out with MeOH – H O (6.5 : 3.5). The effluent
2
was collected in 10-mL fractions monitored by TLC
using MeOH – H O (8 : 2) as solvent system, and the
2
developed TLCs were heated after spraying with vanillin/
sulfuric acid spray reagent. Similar fractions were pooled to-
gether. After further purification through re-crystallization
from hot methanol (60 °C), two main compounds were
isolated as yellow plates; CS1 (310mg) and CS2 (220mg).
Cell line. A mouse melanoma cell line, B16 and mouse
neuroblastoma cells neuro-2Awere obtained from RIKEN
Cell Bank. The cells were maintained in EMEM supple-
mented with 10% (v/v) fetal bovine serum (FBS) and
0.09mg/mL theophylline. Adult normal human dermal
fibroblasts (NHDF-Ad, Lonza, Tokyo, Japan) were rou-
tinely maintained in 10% FBS in Dulbecco’s modified
Eagle’s medium (DMEM). All of cultivation was con-
ducted at 37°C in a humidified atmosphere of 5% CO2.
Anti-obesity activity. The pancreatic lipase inhibition
activity of both compounds was measured by an in vitro
enzyme reaction, which use 4-methylumbelliferyl oleate
(4-MUO) as the substrate (Mizutani et al., 2010). Each
sample was dissolved in DMSO (400 and 800 μg/mL) and
diluted in 25 μL of buffer solution consisting of 13mM
Tris–HCl, 150mM NaCl and 1.3 mM CaCl (pH =8).
2
Melanin assay in B16 melanoma cell line. This assay was
determined as described previously (Ashour et al.,
These samples were applied to a 96-well plate. DMSO
and Orlistat (final concentration 1 μM) were used as a
negative control and positive control, respectively. Then,
2
2
013). The cells (1mL) were placed in two plates of
4-well plastic culture plates (one plate for determining
5
0 μL of 0.25 mM 4-MUO (dissolved in buffer) was ap-
plied, followed by the addition of 25 μL of lipase enzyme
50 U/mL) to all wells except blank wells as well as sam-
ple blank wells. After plates were incubated for 30min at
5°C, 100 μL of 0.1 M sodium citrate buffer (pH 4.2) was
added to each well to stop the reaction. The amount of
-MUO released by the action of the lipase was measured
melanin and the other for cell viability) at a density of
5
1
×10 cells/well and incubated for 24h in media prior
(
to being treated with the samples. After 24 h, the media
were replaced with 998 μL of fresh media and 2 μL of
the test sample at their maximum solubility (n = 3). At
the same time, negative control (2-μL DMSO) and pos-
itive control, and arbutin at concentration 50mg/mL in
DMSO were tested. The cells were incubated for an ad-
ditional 48h, and then the medium was replaced with
fresh medium containing each sample. After 24h, the
remaining adherent cells were assayed. To determine
the melanin content (for one plate) after removing the
medium and washing the cells with PBS, the cell pellet
was dissolved in 1.0 mL of 1 N NaOH. After overnight
keeping in dark, the crude cell extracts were assayed
by using a microplate reader at 405nm to determine
the melanin content. The results from the cells treated
with the test samples were analyzed as a percentage of
the results from the control culture. On the other hand,
cell viability was determined by using MTT assay which
provides a quantitative measure of the number of viable
cells by determining the amount of formazan crystals
produced by metabolic activity in treated versus control
2
4
with a fluorescence spectrophotometer (FlexStation 3
Microplate Reader, Molecular Devices, CA, USA) at
excitation and emission wavelengths of 355 and 460nm,
respectively.
Adipocyte differentiation inhibition assay. The effects of
the two isolated compounds on adipocyte differentia-
tion were examined as previously described (Zhang
et al., 2012 and Wu et al., 2013). Briefly, 3T3-L1 cells were
seeded into collagen-coated 24-well plates (IWAKI,
5
Tokyo, Japan) at a density of 0.8×10 cells/well. Two days
after confluence, the medium was changed to differentia-
tion medium containing 10% FBS, 10 μg/mL insulin
(Wako, Tokyo Japan), 1-μM dexamethasone (Wako,
Tokyo, Japan), and 0.5mM 3-isobutyl-1-methylxanhine
Copyright © 2016 John Wiley & Sons, Ltd.
Phytother. Res. 30: 835–841 (2016)